Top

Published in:

Open Access 01-01-2021 | Amyotrophic Lateral Sclerosis | COVID-19

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

Authors: Alessandro Bombaci, Gianmarco Abbadessa, Francesca Trojsi, Letizia Leocani, Simona Bonavita, Luigi Lavorgna, on behalf of the Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology

Published in: Neurological Sciences | Issue 1/2021

Abstract

Over the last months, due to coronavirus disease (COVID-19) pandemic, containment measures have led to important social restriction. Healthcare systems have faced a complete rearrangement of resources and spaces, with the creation of wards devoted to COVID-19 patients. In this context, patients affected by chronic neurological diseases, such as amyotrophic lateral sclerosis (ALS), are at risk to be lost at follow-up, leading to a higher risk of morbidity and mortality. Telemedicine may allow meet the needs of these patients. In this commentary, we briefly discuss the digital tools to remotely monitor and manage ALS patients. Focusing on detecting disease progression and preventing life-threatening conditions, we propose a toolset able to improve ALS management during this unprecedented situation.

WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020.

Technology enabled care services. Resource for Commissioners. January 2015. NHS Commissioning Assembly. https://www.england.nhs.uk/wp-content/uploads/2014/12/TECS_FinalDraft_0901.pdf

Waldman G, Mayeux R, Claassen J, Agarwal S, Willey J, Anderson E, Punzalan P, Lichtcsien R, Bell M, Przedborski S, Ulane C, Roberts K, Williams O, Lassman AB, Lennihan L, Thakur KT (April 2020) Preparing a neurology department for SARS-CoV-2 (COVID-19): early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City. Neurology. 94:886–891. https://doi.org/10.1212/WNL.0000000000009519CrossRefPubMed

Bonavita S, Tedeschi G, Atreja A, Lavorgna L (2020) Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic. Neurol Sci 41(5):1007–1009. https://doi.org/10.1007/s10072-020-04391-9CrossRefPubMed

Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3(1):17071. https://doi.org/10.1038/nrdp.2017.71CrossRefPubMed

Lombardi V, Bombaci A, Zampedri L, et al. (2020) Plasma pNfH levels differentiate SBMA from ALS. Journal of Neurology, Neurosurgery and Psychiatry. 91(2). https://doi.org/10.1136/jnnp-2019-320624

Brown RH, Al-Chalabi A (2017 Jul 13) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162–172. https://doi.org/10.1056/NEJMra1603471CrossRefPubMed

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC, Quality Standards Subcommittee of the American Academy of Neurology (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 73(15):1218–1226. https://doi.org/10.1212/WNL.0b013e3181bc0141CrossRefPubMedPubMedCentral

Bakker L, Schröder C, Tan H et al (2020) Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R. J Neurol Neurosurg Psychiatry 91:75–81. https://doi.org/10.1136/jnnp-2019-321138CrossRefPubMed

10.

Berry JD, Paganoni S, Carlson K, Burke K, Weber H, Staples P, Salinas J, Chan J, Green JR, Connaghan K, Barback J, Onnela JP (2019) Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol 6(5):873–881. https://doi.org/10.1002/acn3.770CrossRefPubMedPubMedCentral

11.

American Academy of Neurology. Telemedicine and remote care. AAN COVID-19 Neurol Resour. https://www.aan.com/tools-and-resources/practicing-neurologists-administrators/telemedicine-and-remote-care/. Accessed April 25, 2020

12.

Pulley MT, Brittain R, Hodges W, Frazier C, Miller L, Matyjasik-Liggett M, Maurer S, Peters M, Solomon K, Berger AR (2019) Multidisciplinary amyotrophic lateral sclerosis telemedicine care: the store and forward method. Muscle Nerve 59(1):34–39. https://doi.org/10.1002/mus.26170CrossRefPubMed

13.

Awadallah M, Janssen F, Körber B, Breuer L, Scibor M, Handschu R (2018) Telemedicine in general neurology: interrater reliability of clinical neurological examination via audio-visual telemedicine. Eur Neurol 80(5–6):289–294. https://doi.org/10.1159/000497157CrossRefPubMed

14.

Garcia-Gancedo L, Kelly ML, Lavrov A, et al. (2019) Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: observational study. J Med Internet Res. 21(12). https://doi.org/10.2196/13433

15.

Pinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, De Carvalho M (2010) Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 81(11):1238–1242. https://doi.org/10.1136/jnnp.2010.206680CrossRefPubMed

16.

Allison KM, Yunusova Y, Campbell TF, Wang J, Berry JD, Green JR. (2018) The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS HHS Public Access. https://doi.org/10.1080/21678421.2017.1303515

17.

Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA (2019) Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol 19(1):104. https://doi.org/10.1186/s12883-019-1330-6CrossRefPubMedPubMedCentral

18.

Brearly TW, Shura RD, Martindale SL, Lazowski RA, Luxton DD, Shenal BV, Rowland JA (2017) Neuropsychological test administration by videoconference: a systematic review and meta-analysis. Neuropsychol Rev 27(2):174–186. https://doi.org/10.1007/s11065-017-9349-1CrossRefPubMed

19.

Vitacca M, Comini L, Tentorio M, Assoni G, Trainini D, Fiorenza D, Morini R, Bruletti G, Scalvini S (2010) A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J Telemed Telecare 16(2):83–88. https://doi.org/10.1258/jtt.2009.090604CrossRefPubMed

20.

Pinto S, Quintarelli S, Silani V (2020) New technologies and amyotrophic lateral sclerosis – which step forward rushed by the COVID-19 pandemic? J Neurol Sci 418:117081. https://doi.org/10.1016/j.jns.2020.117081CrossRefPubMedPubMedCentral

21.

Aghdam MRF, Vodovnik A, Hameed RA (2019) Role of telemedicine in multidisciplinary team meetings. J Pathol Inform;10:35. Published 2019 Nov 18. https://doi.org/10.4103/jpi.jpi_20_19

22.

De Marchi F, Cantello R, Ambrosini S, Mazzini L, CANPALS Study Group (2020) Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci 41(6):1365–1367. https://doi.org/10.1007/s10072-020-04457-8CrossRefPubMed

23.

Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, Shaw PJ, Walsh T, Wolstenholme D, Mcdermott CJ (2018) The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design. Amyotroph Lateral Scler Frontotemporal Degener. 19(5–6):351–361. https://doi.org/10.1080/21678421.2018.1440408CrossRefPubMed

24.

Hobson EV, Baird WO, Bradburn M et al. (2019) Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study. BMJ Open;9(10):e028525. Published 2019 Oct 22. https://doi.org/10.1136/bmjopen-2018-028525

25.

Geronimo A, Simmons Z (2019) Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 20(5–6):348–355. https://doi.org/10.1080/21678421.2019.1587633CrossRefPubMed

26.

Ricci G, Baldanzi S, Seidita F, Proietti C, Carlini F, Peviani S, Antonini G, Vianello A, Siciliano G, Musumeci O, Toscano A, Ravaglia S, Moggio M, Comi G, Pegoraro E, Filosto M, Marrosu G, Maggi L, Liguori R, Massa R, di Iorio G, Servidei S, Angelini C, Mongini T (2018) A mobile app for patients with Pompe disease and its possible clinical applications. Neuromuscul Disord 28(6):471–475. https://doi.org/10.1016/j.nmd.2018.03.005CrossRefPubMed

27.

Vasta R, Moglia C, D’Ovidio F, di Pede F, de Mattei F, Cabras S, Peotta L, Iazzolino B, Giusiano S, Manera U, Palumbo F, Bombaci A, Torrieri MC, Ilardi A, Mastro E, Arcari M, Solero L, Grassano M, Daviddi M, Matteoni E, Salamone P, Fuda G, Canosa A, Chiò A, Calvo A (2020) Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration:1–4. https://doi.org/10.1080/21678421.2020.1820043

Title: Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
Authors: Alessandro Bombaci
Gianmarco Abbadessa
Francesca Trojsi
Letizia Leocani
Simona Bonavita
Luigi Lavorgna
on behalf of the Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology
Publication date: 01-01-2021
Publisher: Springer International Publishing
Keywords: Amyotrophic Lateral Sclerosis
Neurological Tests
COVID-19
Telemedicine
Published in: Neurological Sciences / Issue 1/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04783-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Black blood MRI: endotheliopathy of Susac syndrome unmasked

Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report

Congenital superior oblique palsy in a patient with Holt-Oram syndrome

“Mozart effect” for Parkinson’s disease: music as medicine

Severe acquired brain injury and high specialty neurorehabilitation needs

Cognitive function: holarchy or holacracy?